These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 28125604

  • 1. Increased Symmetric Dimethylarginine Level Is Associated with Worse Hospital Outcomes through Altered Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction.
    Lorin J, Guilland JC, Stamboul K, Guenancia C, Cottin Y, Rochette L, Vergely C, Zeller M.
    PLoS One; 2017; 12(1):e0169979. PubMed ID: 28125604
    [Abstract] [Full Text] [Related]

  • 2. Circulating levels of dimethylarginines, chronic kidney disease and long-term clinical outcome in non-ST-elevation myocardial infarction.
    Cavalca V, Veglia F, Squellerio I, De Metrio M, Rubino M, Porro B, Moltrasio M, Tremoli E, Marenzi G.
    PLoS One; 2012; 7(11):e48499. PubMed ID: 23185262
    [Abstract] [Full Text] [Related]

  • 3. Nitric oxide dysregulation in patients with heart failure: the association of depressive symptoms with L-arginine, asymmetric dimethylarginine, symmetric dimethylarginine, and isoprostane.
    Mommersteeg PM, Schoemaker RG, Eisel UL, Garrelds IM, Schalkwijk CG, Kop WJ.
    Psychosom Med; 2015 Apr; 77(3):292-302. PubMed ID: 25790241
    [Abstract] [Full Text] [Related]

  • 4. Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction.
    Zeller M, Korandji C, Guilland JC, Sicard P, Vergely C, Lorgis L, Beer JC, Duvillard L, Lagrost AC, Moreau D, Gambert P, Cottin Y, Rochette L.
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):954-60. PubMed ID: 18276906
    [Abstract] [Full Text] [Related]

  • 5. Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam study.
    Wirth J, Atzler D, di Giuseppe R, Cordts K, Menzel J, Böger RH, Boeing H, Weikert C, Schwedhelm E.
    Amino Acids; 2017 Jan; 49(1):173-182. PubMed ID: 27796501
    [Abstract] [Full Text] [Related]

  • 6. Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction.
    Korandji C, Zeller M, Guilland JC, Vergely C, Sicard P, Duvillard L, Gambert P, Moreau D, Cottin Y, Rochette L.
    Clin Biochem; 2007 Jan; 40(1-2):66-72. PubMed ID: 17020756
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Time course of asymmetric dimethylarginine and symmetric dimethylarginine levels after successful renal transplantation.
    Claes KJ, Bammens B, Kuypers DR, Meijers B, Naesens M, Sprangers B, Vanrenterghem Y, Lerut E, de Loor H, Evenepoel P.
    Nephrol Dial Transplant; 2014 Oct; 29(10):1965-72. PubMed ID: 24957811
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion.
    Sen N, Ozlu MF, Akgul EO, Kanat S, Cayci T, Turak O, Yaman H, Sokmen E, Ozcan F, Maden O, Demir AD, Covic A, Kanbay M.
    Atherosclerosis; 2011 Nov; 219(1):304-10. PubMed ID: 21726864
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria.
    Zobel EH, von Scholten BJ, Reinhard H, Persson F, Teerlink T, Hansen TW, Parving HH, Jacobsen PK, Rossing P.
    Cardiovasc Diabetol; 2017 Jul 11; 16(1):88. PubMed ID: 28697799
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Proenkephalin and prognosis after acute myocardial infarction.
    Ng LL, Sandhu JK, Narayan H, Quinn PA, Squire IB, Davies JE, Bergmann A, Maisel A, Jones DJ.
    J Am Coll Cardiol; 2014 Jan 28; 63(3):280-9. PubMed ID: 24140658
    [Abstract] [Full Text] [Related]

  • 18. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology?
    Busch M, Fleck C, Wolf G, Stein G.
    Amino Acids; 2006 May 28; 30(3):225-32. PubMed ID: 16680555
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.